Neo Health (OTC) is a leading pharmaceutical product and service provider. We are proudly Australian-owned, with over 25 years of experience servicing the pharmaceutical industry. We provide the most extensive range of market-ready, TGA registered & listed, over-the-counter and prescription products, as well as vitamins, mineral supplements, medical devices, and various other niche products for our clients. We partner with major pharmaceutical companies, pharmacy chains and grocery retailers to provide them with a range of products for the Australian market. With over 250 TGA approved products available, plus over 250 in various stages of development and regulatory approval, Neo Health (OTC) provides unparalleled innovation that offers our clients the latest in new pharmaceutical products to expand and enhance their product portfolios. Whether it’s filling a specific gap in an existing range or creating an entirely new line of products, Neo Health (OTC) is your trusted partner. Our unique service offering takes your product ideas from concept to shelf. Our visionary leadership, expert team and commitment to research & development inform our strategic portfolio planning and gap analysis allowing us to provide recommendations to our clients for their future product ranges. Our extensive global and local network of pharmaceutical manufacturing partners, combined with our industry-leading IP services, compliance, and regulatory services, ensures that our products adhere to the highest standards. Furthermore, our state-of-the-art logistics and supply chain capabilities ensure your products arrive on time, every time, to maximise your success and grow your market share.
There is no investment information
No recent news or press coverage available for Neo Health (OTC).